Abstract
Dyslipidaemia is a modifiable cause of increased mortality in patients with mental illness. We described prevalence, aetiology and treatment of dyslipidaemia in patients with mental illness. Patients with mental illness have a higher prevalence of dyslipidaemia than the general population due to genetic predisposition, unhealthy lifestyle and/or psychotropic medications. Attention towards early identification of dyslipidaemia, close monitoring, and a low threshold for initiating treatment with lifestyle interventions and lipid-lowering agents are warranted in patients with mental illness.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 184 |
| Udgave nummer | 10 |
| ISSN | 0041-5782 |
| Status | Udgivet - 7 mar. 2022 |
Emneord
- Dyslipidemias/complications
- Humans
- Life Style
- Mental Disorders/complications
- Prevalence
- Psychotropic Drugs
Fingeraftryk
Dyk ned i forskningsemnerne om 'Dyslipidaemia in patients with mental illness'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS